home / stock / seer / seer quote
Last: | $1.62 |
---|---|
Change Percent: | 0.61% |
Open: | $1.63 |
Close: | $1.62 |
High: | $1.64 |
Low: | $1.6 |
Volume: | 339,627 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.62 | $1.63 | $1.62 | $1.64 | $1.6 | 339,627 | 07-05-2024 |
$1.64 | $1.65 | $1.64 | $1.665 | $1.63 | 221,239 | 07-04-2024 |
$1.64 | $1.65 | $1.64 | $1.665 | $1.63 | 221,239 | 07-03-2024 |
$1.64 | $1.68 | $1.64 | $1.6979 | $1.62 | 742,962 | 07-02-2024 |
$1.69 | $1.7 | $1.69 | $1.77 | $1.675 | 865,210 | 07-01-2024 |
$1.68 | $1.78 | $1.68 | $1.81 | $1.65 | 7,866,418 | 06-28-2024 |
$1.75 | $1.69 | $1.75 | $1.8 | $1.66 | 702,990 | 06-27-2024 |
$1.67 | $1.66 | $1.67 | $1.73 | $1.66 | 614,195 | 06-26-2024 |
$1.7 | $1.73 | $1.7 | $1.74 | $1.69 | 659,707 | 06-25-2024 |
$1.73 | $1.71 | $1.73 | $1.75 | $1.67 | 544,531 | 06-24-2024 |
$1.7 | $1.66 | $1.7 | $1.73 | $1.64 | 714,046 | 06-21-2024 |
$1.65 | $1.67 | $1.65 | $1.67 | $1.62 | 512,839 | 06-20-2024 |
$1.67 | $1.71 | $1.67 | $1.74 | $1.67 | 370,291 | 06-19-2024 |
$1.67 | $1.71 | $1.67 | $1.74 | $1.67 | 370,291 | 06-18-2024 |
$1.72 | $1.78 | $1.72 | $1.78 | $1.72 | 405,799 | 06-17-2024 |
$1.78 | $1.82 | $1.78 | $1.84 | $1.74 | 421,948 | 06-14-2024 |
$1.81 | $1.89 | $1.81 | $1.9 | $1.81 | 250,960 | 06-13-2024 |
$1.87 | $1.87 | $1.87 | $1.91 | $1.825 | 518,972 | 06-12-2024 |
$1.81 | $1.8 | $1.81 | $1.83 | $1.7575 | 364,267 | 06-11-2024 |
$1.81 | $1.73 | $1.81 | $1.825 | $1.685 | 874,857 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CIT...
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to da...
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Achieved reven...